Looft-Wilson RC, Ashley BS, Billig JE, Wolfert MR, Ambrecht LA, Bearden SE. Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries. Am J Physiol Regul Integr Comp Physiol 295: R59 -R66, 2008. First published April 30, 2008 doi:10.1152/ajpregu.00833.2007.-Hyperhomocysteinemia (HHcy) impairs endothelium-dependent vasodilation by increasing reactive oxygen species, thereby reducing nitric oxide (NO ⅐ ) bioavailability. It is unclear whether reduced expression or function of the enzyme that produces NO ⅐ , endothelial nitric oxide synthase (eNOS), also contributes. It is also unclear whether resistance vessels that utilize both NO ⅐ and non-NO ⅐ vasodilatory mechanisms, undergo alteration of non-NO ⅐ mechanisms in this condition. We tested these hypotheses in male C57BL/6 mice with chronic HHcy induced by 6-wk high methionine/low-B vitamin feeding (Hcy: 89.2 Ϯ 49.0 M) compared with age-matched controls (Hcy: 6.6 Ϯ 1.9 M), using first-order mesenteric arteries. Dilation to ACh (10 Ϫ9 -10 Ϫ4 M) was measured in isolated, cannulated, and pressurized (75 mmHg) arteries with and without N G -nitro-L-arginine methyl ester (L-NAME) (10 Ϫ4 M) and/or indomethacin (10 Ϫ5 M) to test endothelium-dependent dilation and non-NO ⅐ -dependent dilation, respectively. The time course of dilation to ACh (10 Ϫ4 M) was examined to compare the initial transient dilation due to non-NO ⅐ , non-prostacyclin mechanism and the sustained dilation due to NO ⅐ . These experiments indicated that endothelium-dependent dilation was attenuated (P Ͻ 0.05) in HHcy arteries due to downregulation of only NO ⅐ -dependent dilation. Western blot analysis indicated significantly less (P Ͻ 0.05) basal eNOS and phospho-S1179-eNOS/eNOS in mesenteric arteries from HHcy mice but no difference in phospho-T495-eNOS/eNOS. S1179 eNOS phosphorylation was also significantly less in these arteries when stimulated with ACh ex vivo or in situ. Real-time PCR indicated no difference in eNOS mRNA levels. In conclusion, chronic dietinduced HHcy in mice impairs eNOS protein expression and phosphorylation at S1179, coincident with impaired NO ⅐ -dependent dilation, which implicates dysfunction in eNOS post-transcriptional regulation in the impaired endothelium-dependent vasodilation and microvascular disease that is common with HHcy.